TAIPEI, Taiwan, Oct. 4, 2020 /PRNewswire/ -- TaiGen Biotechnology Company, Limited ("TaiGen") announced today that it has filed an Investigational New Drug (IND) application with the US FDA for its influenza antiviral TG-1000. TG-1000 is a novel pan-influenza antiviral, which interrupts...
from PR Newswire: https://ift.tt/3jvy5FD
No comments:
Post a Comment